United States Antimony Corporation filed its Form 10-Q for the quarterly period ended June 30, 2026, with the SEC, reporting a net loss of $11,184,200 for the first six months of the year alongside significant balance sheet growth.

Key Highlights

  • Six-month net loss: The company reported a net loss of $11,184,200 for the six months ended June 30, 2026, compared to net income of $728,079 in the same period of 2025.
  • Q2 net income: For the three months ended June 30, 2026, the company reported net income of $110,290, down from $181,555 in Q2 2025.
  • Revenue decline: Six-month revenues were $14,709,670, compared to $17,525,128 in the first half of 2025.
  • Total assets: Total assets grew to $190,616,714 as of June 30, 2026, from $153,925,669 at December 31, 2025.
  • Cash position: Cash and cash equivalents increased to $41,434,379 from $30,494,320 at year-end 2025.
  • Shares outstanding: As of August 7, 2026, there were 149,669,384 shares of $0.01 par value common stock outstanding.
  • Operating expenses surge: Total operating expenses for the six months were $16,190,859, compared to $4,831,276 in the prior-year period, driven primarily by salaries and benefits of $10,104,153.

United States Antimony Reports Higher Losses and Expanded Balance Sheet in First Half 2026

According to the filing, United States Antimony Corporation (NYSE:UAMY) reported revenues of $14,709,670 for the six months ended June 30, 2026, a decrease from $17,525,128 in the same period of 2025. Gross profit fell to $1,692,764 from $5,209,275, as cost of revenues rose to $13,016,906 from $12,315,853. The resulting loss from operations for the first half was $(14,498,095), compared to income from operations of $377,999 in the prior-year period.

The filing shows that total operating expenses for the six-month period reached $16,190,859, up substantially from $4,831,276 a year earlier. Salaries and benefits accounted for $10,104,153 of that total, versus $2,365,061 in the first half of 2025. Professional fees reached $2,370,685, and general and administrative expenses were $2,942,226. Partially offsetting the operating loss, the company disclosed unrealized gains on investment in equity securities of $2,724,823 and interest and investment income of $753,900 in the six-month period. For the second quarter alone, the company recorded an unrealized gain on equity securities of $6,786,253, which helped produce net income of $110,290 for that quarter.

The balance sheet, as reported, expanded materially. Total assets reached $190,616,714 at June 30, 2026, compared to $153,925,669 at December 31, 2025. Inventories increased to $21,605,870 from $12,522,009, and property, plant and equipment, net, rose to $53,449,214 from $42,374,839. Investment in equity securities was reported at $43,219,151, up from $40,494,328. Total stockholders' equity stood at $181,021,838, compared to $140,955,189 at year-end 2025. The accumulated deficit widened to $(56,672,749) from $(45,488,549). Basic and diluted net loss per share for the six-month period were each reported as $(0.08).

What Was Disclosed

United States Antimony Corporation disclosed its unaudited condensed consolidated financial results for the six months and three months ended June 30, 2026, including a six-month net loss of $11,184,200, revenue of $14,709,670, and total assets of $190,616,714.